Table 4 Perioperative complications (n=21a) CTCAE ver 4.0

From: Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer

 

Grade 1, n (%)

Grade 2, n (%)

Grade 3, n (%)

All, n (%)

Recurrent laryngeal nerve palsy

5 (23.8)

2 (9.5)

1 (4.8)

8 (38.1)

Pleural effusion

4 (19.0)

1 (4.8)

0

5 (23.8)

Lung infection

0

2 (9.5)

1 (4.8)

3 (14.3)

Postoperative haemorrhage

0

2 (9.5)

0

2 (9.5)

Wound infection

0

1 (4.8)

1 (4.8)

2 (9.5)

Pulmonary fistula

0

1 (4.8)

1 (4.8)

2 (9.5)

Dysphagia

0

1 (4.8)

1 (4.8)

2 (9.5)

Dyspnoea

0

1 (4.8)

0

1 (4.8)

  1. Abbreviation: CTCAE=Common Terminology Criteria of Adverse Events.
  2. aNumber includes patients who underwent conversion oesophagectomy (n=20) and patients who underwent exploratory thoracotomy (n=1).
Back to article page